Pharmaceuticals

International Edition

Simpson Thacher and Davis Polk bag lead roles on AstraZeneca's $2.7bn US pharma acquisition

By Vern Pitt | November 9, 2015

UK pharmaceutical giant turns to US firm as it buys kidney disease treatment maker ZS Pharma amid booming M&A market

1 minute read

Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn

By Anna Ward | November 2, 2015

Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax

1 minute read
International Edition

Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn

By Anna Ward | November 2, 2015

Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax

1 minute read

Latham and Simpson Thacher advise on $8bn science real estate buyout

By Rose Walker | October 9, 2015

US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust

1 minute read
International Edition

Latham and Simpson Thacher advise on $8bn science real estate buyout

By Rose Walker | October 9, 2015

US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust

1 minute read
International Edition

Clifford Chance and Sullivan & Cromwell lead on $3.5bn pharma deal

By James Booth | September 9, 2015

Clifford Chance and Sullivan & Cromwell lead as Cinven sells Amdipharm Mercury

1 minute read
US firms monopolise pharma deals as market swells

By Rose Walker | September 8, 2015

US firms dominate as pharma sector booms, with 2015 seeing some of the biggest deals of the last three years

1 minute read
International Edition

US firms monopolise pharma deals as market swells

By Rose Walker | September 8, 2015

US firms dominate as pharma sector booms, with 2015 seeing some of the biggest deals of the last three years

1 minute read
Sullivan and Skadden get it on for $1bn takeover of 'female Viagra' maker

By Anna Ward | August 21, 2015

US firms called in as Valeant agrees to buy Sprout after its libido enhancing drug gained regulatory approval this week

1 minute read
International Edition

Sullivan and Skadden get it on for $1bn takeover of 'female Viagra' maker

By Anna Ward | August 21, 2015

US firms called in as Valeant agrees to buy Sprout after its libido enhancing drug gained regulatory approval this week

1 minute read
Law.com

Opioid Judge Has Concerns About Motley Rice: 'I Can't Understand Why You Don't See That'

By Amanda Bronstad | February 27, 2024

U.S. District Judge Dan Polster, who is weighing a disqualification motion in the opioid multidistrict litigation, raised concerns this month about Motley Rice obtaining confidential information while representing the state of Hawaii, the District of Columbia and the city of Chicago in other cases.

6 minute read
Corporate Counsel

Walgreens Goes Outside Retailing to Hire New Legal Chief

By Maria Dinzeo | February 27, 2024

Lanesha Minnix's appointment completes the executive committee for CEO Tim Wentworth, who came out of retirement in October to take the post.

3 minute read
The Recorder

CVS Administered Wrong RSV Vaccine to Pregnant Woman, Class Action Alleges

By Marianna Wharry | February 23, 2024

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be first to know about new suits in your region, practice area or client sector.

3 minute read
The Legal Intelligencer

Meet the Pennsylvania Judge Overseeing the Ozempic MDL

By Aleeza Furman | Amanda Bronstad | February 20, 2024

"Civility helps bring out the best in people," Pratter said, "just like being uncivil tends to hide the merits of a case and unnecessarily inflames people to get involved in side squabbles that do not move the case along."

4 minute read
The Legal Intelligencer

Former GSK Patent Leader Moves to Troutman Pepper

By Amanda O'Brien | February 16, 2024

Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.

2 minute read
New Jersey Law Journal

LexisNexis Accused of Disseminating Private Information

By Charles Toutant | February 9, 2024

A court can award actual damages of at least $1,000 for each violation, punitive damages for reckless or willful disregard of the law, and attorney fees and litigation costs.

3 minute read
New Jersey Law Journal

New Jersey Pursues Wyeth, a Pfizer Subsidiary, Over Chemical Disposal

By Charles Toutant | February 9, 2024

The property was used for manufacturing of drugs and chemicals from 1915 to 1999, the suit states. During that period, waste was placed in at least 27 large, pondlike storage and disposal areas that were referred to as impoundments, the suit claims.

4 minute read
New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

By Colleen Murphy | February 9, 2024

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.

7 minute read
New Jersey Law Journal

Class Action Claims Johnson & Johnson Prescription Plan Overcharges Participants

By Colleen Murphy | February 8, 2024

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.

4 minute read
New York Law Journal

US Judge Ends Antitrust Claim Alleging Conspiracy to Manipulate Prices of Insulin Products

By Brian Lee | February 5, 2024

Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.

4 minute read

Featured Employers

Spotlight Job

M&A Partner - leading City Firm

This leading international firm has been a massive success story in recent years. Growth of the Corporate practice, with a number of key market leading partner hires, has further increased the workstr...

Signium

London, Greater London, United Kingdom

More From ALM

Are you managing NDAs with the speed and precision the market demands? Download this guide to learn about the most important terms in private equity NDA to help streamline your workflows.

The Top 10 Terms in Private Equity NDAs

Brought to you by Ontra
Download Now

As private equity fund managers, remaining compliant on every front is critical as the SEC continues to intensify enforcement efforts and propose reforms. Learn how to improve your compliance and face your biggest risks head on in this guide.

Top 10 Compliance Concerns for Private Fund Managers

Brought to you by Ontra
Download Now

Premium Subscription

With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now

Team Accounts

Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now

Bundle Subscriptions

Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now

From Data to Decisions

Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends.

Exclusive Depth and Reach.

Law.com Compass includes access to our exclusive industry reports, combining the unmatched expertise of our analyst team with ALM’s deep bench of proprietary information to provide insights that can’t be found anywhere else.

Big Pictures and Fine Details

Law.com Compass delivers you the full scope of information, from the rankings of the Am Law 200 and NLJ 500 to intricate details and comparisons of firms’ financials, staffing, clients, news and events.